YU44602A - Dnk kod za novi rg1 polipeptid - Google Patents

Dnk kod za novi rg1 polipeptid

Info

Publication number
YU44602A
YU44602A YU44602A YUP44602A YU44602A YU 44602 A YU44602 A YU 44602A YU 44602 A YU44602 A YU 44602A YU P44602 A YUP44602 A YU P44602A YU 44602 A YU44602 A YU 44602A
Authority
YU
Yugoslavia
Prior art keywords
polypeptides
encoding
novel
dnk
polypeptide
Prior art date
Application number
YU44602A
Other languages
English (en)
Inventor
Richard Harkins
Deborah Parkes
Gordon Parry
Douglas W. Schneider
Renate Steinbrecher
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of YU44602A publication Critical patent/YU44602A/sh
Publication of RS50831B publication Critical patent/RS50831B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Priloženi pronalazak se odnosi na novi polipeptid humanog ekstraćelijskog matriksa, označen kao RG1, polinukleotide koji kodiraju polipeptide, metode za proizvodnju polipeptida, vektora ekspresije i genetički izmenjene ćelije domaćina za ekspresiju polipeptida. Pronalazak se dalje odnosi na metode upotrebe polinukleotida i polipeptida u istraživanju, dijagnostici i terapeutskoj primeni.[The present invention relates to novel human extracellular matrix polypeptides, designated RG1, polynucleotides encoding the polypeptides, methods for producing the polypeptides, expression vectors and genetically engineered host cells for expression of the polypeptides. The invention further relates to methods for utilizing the polynucleotides and polypeptides in research, diagnosis, and therapeutic applications.
YUP-446/02A 1999-12-16 2000-12-15 Izolovano antitelo ili fragment antitela koji se specifično vezuju za rg1 polipeptid RS50831B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17237099P 1999-12-16 1999-12-16
US09/732,357 US6682902B2 (en) 1999-12-16 2000-12-07 DNA encoding a novel RG1 polypeptide

Publications (2)

Publication Number Publication Date
YU44602A true YU44602A (sh) 2005-06-10
RS50831B RS50831B (sr) 2010-08-31

Family

ID=26868022

Country Status (32)

Country Link
US (5) US6682902B2 (sh)
EP (2) EP2048157B1 (sh)
JP (1) JP4979867B2 (sh)
KR (1) KR100752434B1 (sh)
CN (1) CN1297566C (sh)
AT (1) ATE440862T1 (sh)
AU (1) AU784674B2 (sh)
BG (1) BG65898B1 (sh)
BR (1) BR0017022A (sh)
CA (1) CA2394574A1 (sh)
CZ (1) CZ299232B6 (sh)
DE (1) DE60042836D1 (sh)
DK (1) DK1237915T3 (sh)
EE (1) EE05293B1 (sh)
ES (1) ES2331106T3 (sh)
HR (1) HRP20020549B1 (sh)
HU (1) HU229001B1 (sh)
IL (2) IL150115A0 (sh)
LT (1) LT5046B (sh)
ME (1) MEP37808A (sh)
MX (1) MXPA02005914A (sh)
NO (1) NO330924B1 (sh)
NZ (1) NZ519598A (sh)
PL (1) PL207634B1 (sh)
PT (1) PT1237915E (sh)
RO (1) RO122543B1 (sh)
RS (1) RS50831B (sh)
RU (1) RU2283130C2 (sh)
SI (2) SI21140A (sh)
SK (2) SK286384B6 (sh)
WO (1) WO2001044291A2 (sh)
ZA (1) ZA200205638B (sh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ528700A (en) * 1998-04-08 2005-02-25 Genentech Inc Novel PRO866 polypeptides and nucleic acids with homology to mindin and spondin proteins
US20020161199A1 (en) * 1998-04-08 2002-10-31 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US6960433B1 (en) 1998-10-19 2005-11-01 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US20070031901A1 (en) * 1999-03-08 2007-02-08 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US6682902B2 (en) * 1999-12-16 2004-01-27 Schering Aktiengesellschaft DNA encoding a novel RG1 polypeptide
NZ544911A (en) * 2003-07-22 2008-12-24 Schering Ag RG1 antibodies and uses thereof
US7294704B2 (en) 2003-08-15 2007-11-13 Diadexus, Inc. Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
US7785591B2 (en) 2004-10-14 2010-08-31 Morphosys Ag Identification and characterization of function-blocking anti-ED-B-fibronectin antibodies
TWI615403B (zh) * 2007-02-21 2018-02-21 腫瘤療法 科學股份有限公司 表現腫瘤相關抗原之癌症的胜肽疫苗
TW200930407A (en) * 2007-11-30 2009-07-16 Medarex Inc Conjugates of anti-RG-1 antibodies
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
CN102346184B (zh) * 2010-08-03 2014-03-26 中国人民解放军军事医学科学院生物工程研究所 Spon2的新用途
DE202012012998U1 (de) 2011-08-31 2014-06-13 Daniel Elias Bioaktive, regenerative Mischung zur Herstellung eines Ergänzungsnahrungsmittels

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657760A (en) 1979-03-20 1987-04-14 Ortho Pharmaceutical Corporation Methods and compositions using monoclonal antibody to human T cells
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5206344A (en) 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4831175A (en) * 1986-09-05 1989-05-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US5246692A (en) * 1986-09-05 1993-09-21 The United States Of America As Represented By The Secretary Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US5437994A (en) 1989-06-15 1995-08-01 Regents Of The University Of Michigan Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US5399493A (en) 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
US5225212A (en) 1989-10-20 1993-07-06 Liposome Technology, Inc. Microreservoir liposome composition and method
US6150584A (en) * 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5877397A (en) 1990-08-29 1999-03-02 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
KR100272077B1 (ko) 1990-08-29 2000-11-15 젠팜인터내셔날,인코포레이티드 이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물
EP0641212A4 (en) 1992-05-14 1997-05-21 Ribozyme Pharm Inc PROCESS AND REAGENT FOR PREVENTING THE DEVELOPMENT OF CANCER.
US5871969A (en) 1996-02-12 1999-02-16 Human Genome Sciences, Inc. Nucleic acids encoding human neuronal attachment factor-1
US6177244B1 (en) * 1996-05-10 2001-01-23 Beth Israel Deaconess Medical Center Inc. NPG-1 gene that is differentially expressed in prostate tumors
US5804382A (en) 1996-05-10 1998-09-08 Beth Israel Deaconess Medical Center, Inc. Methods for identifying differentially expressed genes and differences between genomic nucleic acid sequences
US6287777B1 (en) * 1996-05-10 2001-09-11 Beth Israel Deaconess Medical Center NPG-1 gene that is differentially expressed in prostate tumors
JP3494529B2 (ja) * 1996-06-06 2004-02-09 Ｙｋｋ株式会社 一体成形面ファスナー
AU4236297A (en) * 1996-08-26 1998-03-19 University Of Washington Therapeutic and diagnostic applications of perlecan domain splice variants
WO1998045442A2 (en) 1997-04-10 1998-10-15 Zymogenetics, Inc. Secreted f-spondin homologs
WO1998050554A2 (en) * 1997-05-06 1998-11-12 Human Genome Sciences, Inc. Enterococcus faecalis polynucleotides and polypeptides
WO1998050073A1 (en) 1997-05-09 1998-11-12 Smithkline Beecham Corporation Integrin ligand, human mindin
NZ507435A (en) 1998-03-10 2003-12-19 Genentech Inc Novel polypeptides and nucleic acids with homology to cornichon
US6166176A (en) * 1998-03-17 2000-12-26 Immvarx, Inc. Cancer marker protein and peptides thereof
CA2347085A1 (en) 1998-10-19 2000-04-27 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US6960433B1 (en) * 1998-10-19 2005-11-01 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US6682736B1 (en) * 1998-12-23 2004-01-27 Abgenix, Inc. Human monoclonal antibodies to CTLA-4
US6824780B1 (en) * 1999-10-29 2004-11-30 Genentech, Inc. Anti-tumor antibody compositions and methods of use
US6682902B2 (en) * 1999-12-16 2004-01-27 Schering Aktiengesellschaft DNA encoding a novel RG1 polypeptide

Also Published As

Publication number Publication date
US20090292112A1 (en) 2009-11-26
US20040152139A1 (en) 2004-08-05
AU784674B2 (en) 2006-05-25
DE60042836D1 (de) 2009-10-08
SK8482002A3 (en) 2003-02-04
US6682902B2 (en) 2004-01-27
AU3074601A (en) 2001-06-25
HUP0204224A3 (en) 2004-12-28
US7887804B2 (en) 2011-02-15
SK288147B6 (sk) 2013-12-02
SI1237915T1 (sl) 2009-12-31
NZ519598A (en) 2004-03-26
US7893217B2 (en) 2011-02-22
JP2003521244A (ja) 2003-07-15
LT5046B (lt) 2003-08-25
DK1237915T3 (da) 2009-11-16
RO122543B1 (ro) 2009-08-28
IL150115A0 (en) 2002-12-01
RU2002119208A (ru) 2004-02-27
EP1237915A2 (en) 2002-09-11
CZ299232B6 (cs) 2008-05-21
EE05293B1 (et) 2010-04-15
EP2048157A1 (en) 2009-04-15
EP2048157B1 (en) 2012-10-10
SI21140A (sl) 2003-08-31
ZA200205638B (en) 2003-10-15
JP4979867B2 (ja) 2012-07-18
HRP20020549A2 (en) 2004-04-30
US20020004047A1 (en) 2002-01-10
IL150115A (en) 2013-11-28
EP1237915B1 (en) 2009-08-26
PL356220A1 (en) 2004-06-28
PL207634B1 (pl) 2011-01-31
RU2283130C2 (ru) 2006-09-10
KR100752434B1 (ko) 2007-08-27
ES2331106T3 (es) 2009-12-22
WO2001044291A3 (en) 2002-01-17
NO330924B1 (no) 2011-08-22
MXPA02005914A (es) 2003-02-27
LT2002070A (en) 2003-04-25
EE200200323A (et) 2003-10-15
NO20022836L (no) 2002-08-15
BG65898B1 (bg) 2010-04-30
CN1297566C (zh) 2007-01-31
BG106823A (bg) 2003-04-30
US20090214422A1 (en) 2009-08-27
SK286384B6 (sk) 2008-08-05
US7307154B2 (en) 2007-12-11
PT1237915E (pt) 2009-11-04
RS50831B (sr) 2010-08-31
HU229001B1 (en) 2013-07-29
HUP0204224A2 (hu) 2003-03-28
ATE440862T1 (de) 2009-09-15
BR0017022A (pt) 2002-11-05
WO2001044291A2 (en) 2001-06-21
NO20022836D0 (no) 2002-06-14
HRP20020549B1 (hr) 2013-09-30
CA2394574A1 (en) 2001-06-21
MEP37808A (en) 2011-05-10
KR20020065575A (ko) 2002-08-13
CN1434832A (zh) 2003-08-06
US20040023307A1 (en) 2004-02-05

Similar Documents

Publication Publication Date Title
YU44602A (sh) Dnk kod za novi rg1 polipeptid
ATE319827T1 (de) Polypeptid, das die differenzierung unterdrueckt
ZA941644B (en) Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-3 and uses thereof
AU2001287639A1 (en) Trp8, trp9 and trp10, markers for cancer
EP1082433A4 (en) Interleukins 21 and 22
WO1999032516A3 (en) Pharmaceutical compositions containing the long pentraxin ptx3
PT963377E (pt) Interleucina 19
NO20011460L (no) Cytokinreseptor zalphall
IL126152A0 (en) Recombinant adenoviral vectors for human tumor gene therapy
WO2001081577A3 (en) Dna encoding the prost 03 polypeptide
NZ516237A (en) Meth1 and meth2 polynucleotides and polypeptides
MY127669A (en) Polypeptide hormone phosphatonin
GB0120022D0 (en) Conjugate
ES8605296A1 (es) Procedimiento de producir factor viii-r humano
ATE368740T1 (de) Die menschliche beta-1a-untereinheit des potential-abhängigen natriumkanals und deren verwendungen
WO2002066506A3 (en) Use of casb7439 (ash2) in the immunotherapy of breast cancer
WO2000042165A3 (en) Bone marrow-specific protein
WO2000071567A3 (en) Fibroblast growth factor 13
WO2001053344A3 (en) Chondromodulin-i related peptide
WO2001079432A3 (fr) Nouveau polypeptide, facteur humain de transcription de la differentiation cellulaire 58, et polynucleotide codant pour ce polypeptide
WO2001075016A3 (fr) Nouveau polypeptide, tyrosinase humaine 16, et polynucleotide codant pour ce polypeptide
WO2001075010A3 (fr) Nouveau polypeptide, proteine humaine de transduction nucleaire 25 contenant un domaine structurel atp/gtp, et polynucleotide codant pour ce polypeptide
WO2001094540A3 (fr) Nouveau polypeptide, glycosyl hydrolase humaine 23, et polynucleotide codant ce polypeptide